The Patent Finder

Terms ending in 2027

Hoffmann-La Roche Inc.

Every in-force patent on Hoffmann-La Roche Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 7,425,551Malonamide Derivatives
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 7,514,426Substituted Imidazol[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine Derivatives
In force
 · Medium confidence
Hoffmann-La Roche Inc.In forceMedium confidence
US 11,673,958Glycosylated Antibodies
In force
 · Low confidence
Hoffmann-La Roche Inc.In forceLow confidence
US 7,504,544Asymmetric Hydrogenation of 1,1,1- Trifluoroacetone
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 7,642,264Phenyl-Substituted Pyrimidine Derivatives as MG1UR Antagonists
In force
 · High confidence
Hoffmann-La Roche Inc.In forceHigh confidence
US 7,955,806Detection of a Therapeutic Antibody in an Experimental Animal
In force
 · High confidence
Hoffmann-La Roche, Inc.In forceHigh confidence
US 12,559,561Glycosylated Antibodies
In force
 · Medium confidence
Hoffmann-La Roche Inc.In forceMedium confidence
US 8,889,109Novel Pharmaceutical Dosage Forms Comprising Valganciclovir Hydrochloride
In force
 · Medium confidence
Cheplapharm Arzneimittel GmbHIn forceMedium confidence
US 9,642,911Novel Pharmaceutical Dosage Forms Comprising Valganciclovir Hydrochloride
In force
 · Medium confidence
Cheplapharm Arzneimittel GmbHIn forceMedium confidence
US 11,185,588Novel Pharmaceutical Dosage Forms Comprising Valganciclovir Hydrochloride
In force
 · Medium confidence
Cheplapharm Arzneimittel GmbHIn forceMedium confidence
10 of 10 patents shown. Soonest term end first, then patent number.
7 of these are in force and held by Hoffmann-La Roche Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited